J&J to begin human trials of COVID-19 vaccine in second half of July
In This Article:
June 10 (Reuters) - Johnson & Johnson said on Wednesday it would start human trials of its potential COVID-19 vaccine in the second half of July. (Reporting by Saumya Sibi Joseph in Bengaluru; Editing by Saumyadeb Chakrabarty)
Terms and Privacy Policy